Protagenic Therapeutics Inc (PTIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,751 | -2,558 | -2,260 | -2,276 | -1,023 |
| Depreciation Amortization | 12 | 0 | 0 | 405 | 0 |
| Accounts receivable | N/A | N/A | N/A | 6 | N/A |
| Other Working Capital | 702 | 110 | -17 | -2 | 152 |
| Other Operating Activity | 549 | 1,376 | 896 | 727 | 490 |
| Operating Cash Flow | $-488 | $-1,071 | $-1,380 | $-1,140 | $-381 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 250 | 1,046 | -1,286 | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | N/A | -2 |
| Investing Cash Flow | $250 | $1,046 | $-1,286 | $N/A | $-2 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 19 | 388 |
| Debt Issued | 670 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 7 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 4,258 | 0 |
| Financing Cash Flow | $670 | $N/A | $N/A | $4,284 | $388 |
| Exchange Rate Effect | 4 | -12 | -34 | -47 | -24 |
| Beginning Cash Position | 363 | 400 | 3,100 | 3 | 23 |
| End Cash Position | 799 | 363 | 400 | 3,100 | 3 |
| Net Cash Flow | $436 | $-37 | $-2,701 | $3,097 | $-19 |
| Free Cash Flow | |||||
| Operating Cash Flow | -488 | -1,071 | -1,380 | -1,140 | -381 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -2 |
| Free Cash Flow | -488 | -1,071 | -1,380 | -1,140 | -383 |